Trial Details

COMPLETED
Basic Information
Clinical ID c4059
Identifier NCT01106742
Trial Title Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions DIETARY_SUPPLEMENT: AndoSan
Participant Information
Sponsor Ullevaal University Hospital
City Oslo
Country/Region Norway
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2009-03
Primary Completion Date 2011-07
Completion Date 2011-07